Who
Frank D. Lee
Director
Company insider
Files Form 4 as: Director, Bausch Health Companies; Chief Executive Officer, Pacira BioSciences; Director, Bolt Biotherapeutics; President and CEO, Forma Therapeutics Holdings.
In numbers
- Trades disclosed
- 38
- Buys
- 1
- Sells
- 3
- Bought
- $100K
- Sold
- $563K
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 18 Jun 2020
- Last trade
- 22 May 2026
- Last filed
- 26 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 May 2026filed 26 May 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —45,871 at $0.00 | filing |
| 22 May 2026filed 26 May 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —45,871 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Sold | $133K24,456 at $5.43 | filing |
| 19 May 2026filed 20 May 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Sold | $133K24,456 at $5.43 | filing |
| 11 Feb 2026filed 13 Feb 2026 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code A | —261,818 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code A | —261,818 at $0.00 | filing |
| 30 Jan 2026filed 3 Feb 2026 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code F | $852K41,488 at $20.54 | filing |
| 30 Jan 2026filed 3 Feb 2026 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code F | $852K41,488 at $20.54 | filing |
| 2 Jan 2026filed 6 Jan 2026 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code F | $227K9,272 at $24.46 | filing |
| 2 Jan 2026filed 6 Jan 2026 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code F | $227K9,272 at $24.46 | filing |
| 21 Aug 2025filed 22 Aug 2025 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Sold | $122K15,912 at $7.66 | filing |
| 16 May 2025filed 20 May 2025 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —54,347 at $0.00 | filing |
| 1 Feb 2025filed 4 Feb 2025 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code F | $172K9,375 at $18.33 | filing |
| 12 Aug 2024filed 13 Aug 2024 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Bought | $100K8,264 at $12.10 | filing |
| 12 Jun 2024filed 14 Jun 2024 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —35,360 at $0.00 | filing |
| 3 Jan 2024filed 4 Jan 2024 | PCRX Pacira BioSciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —692,512 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | PCRX Pacira BioSciencesPharmaceuticals | SEC FORM 4 Code A | —99,520 at $0.00 | filing |
| 12 Jun 2023filed 14 Jun 2023 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
Contrasting Ocular Therapeutix (NASDAQ:OCUL) and Bausch Health Cos (NYSE:BHC)BHC · dailypolitical.com · 13 Oct 2026Contrasting Bausch Health Cos (NYSE:BHC) and Journey Medical (NASDAQ:DERM)BHC · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Frank D. Lee; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.